Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia.

J Pharm Health Care Sci · 2015 · PMC4729005 · PMID 26819725

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The SMD in the SKT at 26 weeks and 120 mg/day were greater for Ginkgo biloba than for placebo (–0.06 [– 0.41, 0.30]), but the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.